Zanosar

Zanosar (Streptozocin) is an antineoplastic agent used for pancreatic cancer treatment. This chemotherapy drug works by slowing or stopping cancer cell growth. It is administered intravenously under medical supervision. Always consult a healthcare professional before use.

Zanosar is primarily used to treat pancreatic islet cell carcinoma, a rare type of pancreatic cancer. It may also be prescribed for other conditions as determined by a physician. Patients often ask, 'What is Zanosar used for?' to understand its role in cancer therapy. This medication targets rapidly dividing cells to reduce tumor size.

Common effects of Zanosar include nausea, vomiting, and fatigue during treatment. Some patients may experience changes in kidney function or blood cell counts. These effects vary by individual and are typically monitored closely by healthcare providers.

Zanosar should only be handled and administered by trained medical professionals. Pregnant or breastfeeding individuals should avoid exposure due to potential risks. Regular blood tests are necessary to monitor organ function and side effects. Always disclose your full medical history to your doctor before starting treatment.

Zanosar may interact with other medications affecting the liver or kidneys, such as certain antibiotics or diuretics. Alcohol and tobacco use can exacerbate side effects like nausea. Immunosuppressants and live vaccines should be avoided during treatment. Always inform your healthcare provider about all medications you are taking.